Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial

BACKGROUND: Patients with schizophrenia can generally manifest a broad variety of primary negative symptoms. The current study aimed to assess the efficacy and tolerability of resveratrol add-on therapy in the treatment of negative symptoms in patients with stable schizophrenia. METHODS: In a random...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Neuropsychopharmacol
Päätekijät: Samaei, Areoo, Moradi, Kamyar, Bagheri, Sayna, Ashraf-Ganjouei, Amir, Alikhani, Rosa, Mousavi, Seiedeh Bentolhoda, Rezaei, Farzin, Akhondzadeh, Shahin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Regular Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7770519/
https://ncbi.nlm.nih.gov/pubmed/33372679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyaa006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia